Taking valsartan blood pressure stabilization 130/85mmHg can be, continue to maintain the current therapeutic dose, monitoring changes in blood pressure. The main effect of valsartan is to inhibit angiotensin II receptors, which can dilate peripheral blood vessels to reduce blood pressure. Hypertensive patients to control the blood pressure level at <140/90mmHg, 130/85mmHg in the normal control range, such as patients with kidney disease, blood pressure level can be further reduced. Patients with stabilized blood pressure levels on oral valsartan should continue to take it orally at the current dosage while monitoring changes in blood pressure levels. Adverse reactions to valsartan include nausea, dizziness, nausea, cough, flu-like symptoms, muscle aches and pains, angioneurotic edema, etc. It is contraindicated in patients who are allergic to the components of the drug, pregnant lactating females, and patients with severe impaired renal function (creatinine clearance <10ml/min). Patients with hypertension should take valsartan orally under the guidance of a physician, and when changes in blood pressure occur, the dose of the drug should be adjusted under the guidance of a physician.